openPR Logo
Press release

Integrin Beta Market 2021 Size, Growth Analysis Report, Forecast to 2027

03-12-2022 10:48 AM CET | Health & Medicine

Press release from: Orion Market Research

The global integrin beta market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Integrins are proteins that function mechanically. They attach to the cell cytoskeleton to the extracellular matrix (ECM), and biochemically through sensing if adhesion has occurred. The integrin family consists of two types of protein including alpha and beta subtypes. Additionally, there are 8 types of integrin beta-protein such as IGBT1, IGBT2, IGBT3, IGBT4, IGBT5, IGBT6, IGBT7, and IGBT8.

The major factor driving the growth of the increasing prevalence of genetic disorders across the globe. According to the Genetic and Rare Diseases Information Center (GARD), an estimated 25-30 million people are living with a genetic disorder in the US. Moreover, integrins beta regulates cellular growth, proliferation, signaling, as well as cytokine activation. Additionally, it plays important role in cell proliferation and migration, apoptosis, tissue repair.

To Request a Sample of our Report on Integrin Beta Market: https://www.omrglobal.com/request-sample/integrin-beta-market

Some major players in the market include Biogen Inc., and Merck & Co. Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2021, Corbus Pharmaceuticals announced the licesnsing of two integrins through expanding its pipeline in immuno-oncology and fibrotic disease by launching two monoclonal antibodies (mAbs) including CRB-601 and CRB-602. CRB-601 is a high potency anti-alpha V beta 8 (anti-avb8 mAb) antibody while CRB-602 antibody inhibits both alpha V beta 6 and alpha V beta 8.

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Biogen Inc., and Merck & Co., Inc., among others.

(Get 15% Discount on Buying this Report)

A full Report of Integrin Beta Market is Available @ https://www.omrglobal.com/industry-reports/integrin-beta-market

Global Integrin Beta Market Report by Segment

By Type

• ITGB1

• ITGB2

• ITGB3

• ITGB4

• ITGB5

• ITGB6

• ITGB7

• ITGB8

By Application

• Genetic Disorder

• CVD

• Cancer

• Others

Global Integrin Beta Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Integrin Beta Market 2021 Size, Growth Analysis Report, Forecast to 2027 here

News-ID: 2576924 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Integrin

Unveiling Opportunities: Global Integrin Alpha V Market Analysis 2024-2031
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: In the realm of molecular biology and pharmaceuticals, Integrin Alpha V has emerged as a crucial player in cell adhesion, migration, and signaling pathways, presenting significant opportunities for therapeutic interventions. Against the backdrop of the COVID-19 pandemic, understanding the dynamics of the Integrin Alpha V market becomes essential. This blog aims to dissect the market's size, share, and the impact of COVID-19 while exploring key factors driving its growth from
Navigating Growth Avenues: Global Integrin Beta 1 Market Analysis 2024-2031
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: In the realm of molecular biology and pharmaceuticals, Integrin Beta 1 has emerged as a pivotal player in cell adhesion and signaling, offering promising avenues for therapeutic interventions. Against the backdrop of the COVID-19 pandemic, understanding the dynamics of the Integrin Beta 1 market becomes imperative. This blog aims to elucidate the market's size, share, and the impact of COVID-19 while exploring key factors driving its growth from 2024 to
Integrin Beta1 Market Dynamics Unveiled: Recent Trends, Players, and Forecast 20 …
"According to research report the "Integrin Beta1 Market is expected to reach xx Billion by 2034, at a CAGR of xx%".". With thorough company profiles, recent developments, and other information, the Integrin Beta1 Market Report provides an in-depth analysis of major trends, motivating reasons, obstacles, segmentation, regulatory policies, and important players. The Integrin Beta1 Market Report offers a thorough synopsis of the product portfolio, including product development, planning, and positioning of
Integrin Alpha V Market Will Generate Record Revenue by 2029
Integrin alpha V market is anticipated to grow at a significant CAGR during the forecast period. Integrins are proteins that function mechanically. They attach to the cell cytoskeleton to the extracellular matrix (ECM), and biochemically through sensing if adhesion has occurred. The integrin family consists of two types of protein including alpha and beta subtypes. Integrin alpha-V is a protein that is encoded by the ITGAV gene in humans. The
Human Integrin Beta 3 Market: Competitive Dynamics & Global Outlook 2020-2025
Human Integrin Beta 3 This report also researches and evaluates the impact of Covid-19 outbreak on the Human Integrin Beta 3 industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Human Integrin Beta 3 Maker and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). Market Overview The Human Integrin Beta 3 Maker market report provides a detailed analysis of global market
Human Integrin Beta 3 Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Human Integrin Beta 3 market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Human Integrin Beta 3market by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Human Integrin Beta 3market, market definition,